Melissa Davis

Senior Writer

Prior to joining TheStreet.com, Davis worked two years for the Daily Oklahoman, winning the state's top honors for both investigative and business reporting. Before that, she spent two years as managing editor of Durocher's Oklahoma City Business, a local business journal. She has a master's degree in mass communications from the University of Oklahoma and more than 15 years of writing and editing experience.

By This Author:
« Back
Page 1 of 145
Article

Tenet Healthcare Tops Estimates

By Melissa Davis

More patients who pay help the bottom line.

Related Topics: Health Care | Earnings

11:44AM 05/06/08

Article

PharmaNet Shares Get Hammered

By Melissa Davis

A swing to a first-quarter loss blitzes the stock.

Related Topics: Earnings | Health Care

12:45PM 05/01/08

Article

Tenet Converts a Tough Critic

By Melissa Davis

A longtime analyst bear signals it's time to buy.

Related Topics: Health Care

04:57PM 04/25/08

Article

HMA Finally Delivers Strong Results

By Melissa Davis

The company's strong quarter comes amid protests that the company has underperformed.

Related Topics: Health Care

02:24PM 04/23/08

Article

Profit Slumps at WellPoint

By Melissa Davis

The health insurer misses analyst estimates and trims its full-year guidance.

Related Topics: Earnings | Health Care

10:55AM 04/23/08

Article

UnitedHealth Shares Sent Reeling

By Melissa Davis

A management shakeup and a reeled-in forecast makes for a bad combination.

Related Topics: Earnings | Health Care

11:40AM 04/22/08

Article

UnitedHealth Has Investors Worried

By Melissa Davis

The health insurer is feeling the heat of higher costs and customer dissatisfaction.

Related Topics: Health Care

04:50PM 04/21/08

Article

Stryker Continues on a Roll

By Melissa Davis

The medical supply company beats estimates in the first quarter and issues a strong guidance for 2008.

Related Topics: Health Care | Earnings

06:23PM 04/17/08

Article

Schering's Organon Buy Had to Happen

By Melissa Davis

Its acquisition of Organon coincided with a declining part of its drug business.

Related Topics: Health Care

12:58PM 04/09/08

Article

Vytorin Setback Sinks Schering-Plough, Merck

By Melissa Davis

Shares of the drugmakers fall hard after a panel of cardiologists says doctors should limit their prescriptions of the cholesterol medications Vytorin and Zetia.

Related Topics: Health Care | Drugs

03:23PM 03/31/08

« Back
Page 1 of 145
Your Recent Quotes: Quote Up0 | Quote Down0
Dow S&P 500 NASDAQ
Oil*
Gold
10 Yr
0.00%
%
%
%
Data delayed 20 min
Premium Stock Ideas